Glucagon‐like peptide‐1 receptor agonists and incidence of obesity‐related cancer in adults with diabetes: A target‐trial emulation study
Year: 2025
Type: article
Abstract: The authors declare no conflicts of interest. The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.16445. Individual patient level data used in this study cannot be shared due to Optum data use agreements. De-identified, summary level data will be shared on request to the corresponding author in accordance with Optum policy. Data S1. Supporting information. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.16445
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: The Comparative Effectiveness and Safety of Second-line Therapy in Patients with Type 2 Diabetes, Challenges to Guideline-Recommended Diabetes Care in the United States, Prevention and Treatment of Cardiovascular Disease in Patients with Chronic Kidney Disease: Patient-Oriented Research and Mentoring, Maximizing The Benefit of Therapy in CKD
OpenAlex ID: W4410929835